Significance of AZD1152 as a potential treatment against Aurora B overexpression in acute promyelocytic leukemia Samad Ghanizadeh-VesaliAli ZekriSeyed H. Ghaffari Original Article 19 April 2016 Pages: 1031 - 1042
Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies Walid S. HamadouViolaine BourdonZohra Soua Original Article 23 April 2016 Pages: 1043 - 1050
Low-dose decitabine plus all-trans retinoic acid in patients with myeloid neoplasms ineligible for intensive chemotherapy Wei WuYan LinWeiying Gu Original Article 26 April 2016 Pages: 1051 - 1057
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a “Gruppo Romano Mielodisplasie (GROM)” multicenter study Francesco BuccisanoAnna Lina Piccionion behalf of GROM (Gruppo Romano Mielodisplasie) Original Article 19 April 2016 Pages: 1059 - 1065
Correlation between ‘H’ blood group antigen and Plasmodium falciparum invasion Vrushali PathakRoshan ColahKanjaksha Ghosh Original Article 12 April 2016 Pages: 1067 - 1075
Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia Ann JanssensFrancesco RodeghieroJanet Franklin Original Article Open access 30 April 2016 Pages: 1077 - 1087
Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines María Luisa LozanoN. RevillaV. Vicente Original Article 21 April 2016 Pages: 1089 - 1098
Clinical significance of osteoblast precursors and osteoclast precursors in earlier diagnosis and monitoring of myeloma bone disease Rong FuFengping PengZonghong Shao Original Article 27 April 2016 Pages: 1099 - 1106
Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin’s lymphoma: evidence from a multicenter, retrospective study Patrizia MondelloNormann SteinerMichael Mian Original Article 22 April 2016 Pages: 1107 - 1114
Prevalence of clarithromycin-resistant Helicobacter pylori strains in gastric mucosa-associated lymphoid tissue lymphoma patients Ceren BilgilierIngrid Simonitsch-KluppChristoph Steininger Original Article Open access 19 April 2016 Pages: 1115 - 1120
Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma Karin HohlochSamira ZeynalovaNorbert Schmitz Original Article 11 May 2016 Pages: 1121 - 1128
High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin’s lymphoma Igor AurerDamir NemetBoris Labar Original Article 22 April 2016 Pages: 1129 - 1136
A phase 1 clinical trial of flavopiridol consolidation in chronic lymphocytic leukemia patients following chemoimmunotherapy Farrukh T. AwanJeffrey A. JonesLeslie A. Andritsos Original Article 27 April 2016 Pages: 1137 - 1143
The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT) Shinya IshidaNoriko DokiKazuteru Ohashi Original Article 15 April 2016 Pages: 1145 - 1150
Non-myeloablative conditioning for lower-risk myelodysplastic syndrome with bone marrow blasts less than 5 %—a feasibility study Eun-Ji ChoiJe-Hwan LeeKyoo-Hyung Lee Original Article 22 April 2016 Pages: 1151 - 1161
The role of thromboelastography in predicting bleeding risk and guiding the administration of platelet transfusions in hematological patients: a cohort study Xing XinZhaojun LiuDengju Li Original Article 12 April 2016 Pages: 1163 - 1168
Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial Stella Sala Soares LimaVandack NobreJosé Carlos Serufo Original Article 27 April 2016 Pages: 1169 - 1176
Communication during haematological consultations; patients’ preferences and professionals’ performances Inge R. van BruinessenLotte E. van der HoutSandra van Dulmen Original Article 18 April 2016 Pages: 1177 - 1183
Pruritus in primary myelofibrosis: management options in the era of JAK inhibitors Brianna E. VaaAyalew TefferiAlexandra P. Wolanskyj Original Article 23 April 2016 Pages: 1185 - 1189
Safety of pembrolizumab after allogeneic haematopoietic stem cell transplantation Yok-Lam Kwong Letter to the Editor 28 March 2016 Pages: 1191 - 1192
Amisulpride induced agranulocytosis: a case report Lucy PickardNicholas FordhamMickey Koh Letter to the Editor 07 April 2016 Pages: 1193 - 1195
Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia Maximilian StahlMina L. XuAmer M Zeidan Letter to the Editor 11 April 2016 Pages: 1197 - 1200
Influence of single nucleotide polymorphisms in the BCL11A and HBS1L-MYB gene on the HbF levels and clinical severity of sickle cell anaemia patients Dipti UpadhyeDipty JainRoshan Colah Letter to the Editor 20 April 2016 Pages: 1201 - 1203
Early-onset chronic lymphocytic leukaemia in a young man with Cowden syndrome C. MolloyR. CahillJ. Quinn Letter to the Editor 11 May 2016 Pages: 1205 - 1206
Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinib Benoit BrancoDavid MetsuGuillaume Martin-Blondel Letter to the Editor 26 April 2016 Pages: 1207 - 1209
